Weidi Xie

This paper introduces OpenPheno, a multimodal model that predicts bioactivity using phenotypic profiles and natural language descriptions, achieving strong zero-shot performance on unseen assays.

MAP predicts single-cell responses to unprofiled drugs using a knowledge-driven framework that integrates biological knowledge and improves performance over baselines.